Skip to main content

Want a detailed portfolio tracker?

Actuate Therapeutics (ACTU) P/E (2024 - 2026)

Actuate Therapeutics (ACTU) P/E from Sep 30, 2024 to Jul 21, 2026. The TTM Actuate Therapeutics (ACTU) P/E is -1.41. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Actuate Therapeutics (ACTU)

YearP/EChange
2026-1.41-75.95%
2025-5.87-53.11%
2024-12.52N/A

Comparison Actuate Therapeutics (ACTU) P/E with competitors

Actuate Therapeutics (ACTU) P/E is -1.41.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.12%
NBYStablecoin Development Corp0.00-100.30%
ENLVEnlivex Ltd0.07-105.30%
FGENFibroGen Inc0.24-117.01%
CHRSCoherus Biosciences Inc0.85-160.12%
FBIOFortress Biotech Inc0.95-167.24%
ORMPOramed Pharmaceuticals Inc1.50-206.50%
AGENAgenus Inc3.01-313.25%
INVAInnoviva Inc3.15-323.48%
VXRTVaxart Inc3.55-351.52%
CRMDCorMedix Inc3.63-357.10%
CVACCureVac N.V.4.45-415.00%
GLPGGalapagos NV4.86-444.28%
SRPTSarepta Therapeutics Inc4.88-445.92%
ABEOAbeona Therapeutics Inc5.39-481.74%
ABUSArbutus Biopharma Corp5.60-496.48%
ZVRAZevra Therapeutics Inc5.89-517.15%
SPROSpero Therapeutics Inc6.23-541.32%
CGENCompugen Ltd6.31-547.38%
RIGLRigel Pharmaceuticals6.87-586.93%
SLXNSilexion Therapeutics Corp7.30-616.97%
OMEROmeros Corporation9.26-756.04%
AUPHAurinia Pharmaceuticals Inc9.58-779.15%
PLXProtalix BioTherapeutics Inc10.89-871.69%
ACADAcadia Pharmaceuticals Inc11.73-931.04%
TBPHTheravance Biopharma Inc12.26-968.85%
ADMAAdma Biologics Inc12.42-979.90%
HRMYHarmony Biosciences Holdings Inc13.82-1079.25%
SABSSAB Biotherapeutics Inc14.14-1101.64%
NAGENiagen Bioscience Inc14.82-1149.96%
INCYIncyte Corp15.82-1221.13%
REGNRegeneron Pharmaceuticals Inc15.86-1223.54%
PBYIPuma Biotechnology Inc17.32-1326.93%
CPRXCatalyst Pharmaceuticals Inc17.44-1335.68%
EXELExelixis Inc17.54-1342.68%
TGTXTG Therapeutics Inc18.97-1443.86%
MDXGMimedx Group Inc20.55-1556.27%
XOMAXOMA Royalty Corp22.87-1720.86%
ARGXArgen X SE24.30-1821.71%
CTMXCytomX Therapeutics Inc24.82-1858.78%
XOMAOXOMA Royalty Corp25.34-1895.88%
HALOHalozyme Therapeutics Inc25.62-1915.65%
XOMAPXOMA Royalty Corp25.67-1918.94%
VRTXVertex Pharmaceuticals Inc27.99-2083.65%
RPRXRoyalty Pharma plc - Class A28.69-2132.74%
SLNOSoleno Therapeutics Inc29.02-2155.97%
ASNDAscendis Pharma A/S30.09-2231.80%
LGNDLigand Pharmaceuticals Inc - Class B37.91-2786.37%
APLSApellis Pharmaceuticals Inc39.02-2864.97%
BMRNBiomarin Pharmaceutical Inc42.21-3091.05%
KRYSKrystal Biotech Inc45.34-3312.95%
ONCBeiGene Ltd69.54-5027.51%
PHARPharming Group N.V.75.03-5416.17%
TECHBio-Techne Corp101.96-7324.58%
VCELVericel Corp109.92-7888.82%
ALNYAlnylam Pharmaceuticals Inc117.96-8458.79%
GMABGenmab140.29-10040.74%
TLXTelix Pharmaceuticals Ltd162.15-11589.85%
CORTCorcept Therapeutics Inc212.86-15182.69%